Former Novozymes staff revive shelved technology and anticipate million-dollar sales

A group of former Novozymes employees have founded their own biotech company to continue development of a medical technology based on hyaluronic acid. Novozymes scrapped the technology in 2015 but the new company has high aspirations.

Photo: Hyamedix / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles